stockrowACADIA Pharmaceuticals Inc. (ACAD) vs Tarsus Pharmaceuticals, Inc. (TARS)
- ACADIA Pharmaceuticals Inc. ACAD 21.26 +0.09%
- Tarsus Pharmaceuticals, Inc. TARS 67.49 −0.04%
ACADIA Pharmaceuticals Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. ACADIA Pharmaceuticals Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.7B and $3.3B). Tarsus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; ACADIA Pharmaceuticals Inc. trades at 10.0×. Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 86.3% against 14.8%. ACADIA Pharmaceuticals Inc. has the higher net margin (30.1% vs −102.9%) and the higher return on invested capital (18.6% vs 0.00%). Across the 17 metrics below, ACADIA Pharmaceuticals Inc. leads on 14 and Tarsus Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ACAD | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 90.48% | 93.21% | 65.16% |
| Operating margin | 10.17% | (102.04%) | 0.00% |
| Net margin | 30.13% | (102.93%) | 0.00% |
| Free cash flow margin | 6.82% | 4.76% | 0.00% |
| Return on equity | 31.43% | (319.84%) | (50.12%) |
| Return on assets | 23.18% | (135.04%) | (45.60%) |
| Return on invested capital | 18.60% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack